methylimidazoleacetic acid has been researched along with Parkinson Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blandina, P; Burns, RS; Green, JP; Khandelwal, JK; Morrishow, AM; Prell, GD | 1 |
1 other study(ies) available for methylimidazoleacetic acid and Parkinson Disease
Article | Year |
---|---|
Levels of pros-methylimidazoleacetic acid: correlation with severity of Parkinson's disease in CSF of patients and with the depletion of striatal dopamine and its metabolites in MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aged; Animals; Cerebral Cortex; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Humans; Imidazoles; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Parkinson Disease; Reference Values | 1991 |